Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
28.64
-0.28 (-0.97%)
At close: May 17, 2024, 4:01 PM
28.68
+0.04 (0.14%)
After-hours: May 17, 2024, 7:59 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Pfizer stock have an average target of 35.86, with a low estimate of 27 and a high estimate of 50. The average target predicts an increase of 25.21% from the current stock price of 28.64.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pfizer stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 11 | 12 | 10 | 11 | 11 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 16 | 17 | 17 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $29 | Hold | Maintains | $28 → $29 | +1.26% | May 2, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $33 → $36 | Buy | Reiterates | $33 → $36 | +25.70% | May 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +57.12% | Apr 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +57.12% | Apr 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $45 | Buy | Reiterates | $45 | +57.12% | Apr 5, 2024 |
Financial Forecast
Revenue This Year
60.60B
from 58.50B
Increased by 3.59%
Revenue Next Year
63.55B
from 60.60B
Increased by 4.88%
EPS This Year
2.22
from 0.37
Increased by 500.29%
EPS Next Year
2.79
from 2.22
Increased by 25.54%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 63.9B | 68.8B | 70.0B | 73.8B | 76.8B |
| Avg | 60.6B | 63.6B | 64.1B | 64.6B | 62.9B |
| Low | 57.3B | 59.5B | 59.9B | 57.2B | 54.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.3% | 13.5% | 10.1% | 15.1% | 18.8% |
| Avg | 3.6% | 4.9% | 0.8% | 0.8% | -2.7% |
| Low | -2.0% | -1.8% | -5.7% | -10.7% | -16.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.47 | 3.34 | 3.82 | 3.73 | 3.83 |
| Avg | 2.22 | 2.79 | 2.92 | 3.07 | 2.90 |
| Low | 2.01 | 2.18 | 2.40 | 2.43 | 2.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 566.9% | 50.3% | 37.1% | 27.8% | 25.0% |
| Avg | 500.3% | 25.5% | 4.6% | 5.1% | -5.3% |
| Low | 443.0% | -2.0% | -13.9% | -16.7% | -32.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.